IRS1 and Hyperglycemia: According to this study, the hyperglycemia in T2D patients induces the platelet activation through miR-144 and miR-223 to foster the “downregulation of IRS-1 expression and upregulation in the P2Y12 expression” via IRS-1-PI3K-Akt signaling.